Dean, the more I have looked into this technology and discussed it among my colleagues in my own specialty and others, the more immediate interest has been generated in awaiting confirmation of the revolutionary aspects that would change the routine practices of today. A significant reason for IMGG being under appreciated at this stage is both the lack of awareness among the medical doctors in multispecialties and how close to FDA clearance you will be after the Beta Testing is completed.
I am impressed that you have attended the RSNA, Radiologic Society of North America, three years in a row. Often at these international annual medical/surgical meetings, vendors with ostensibly unique technology who show up one year are never seen again in following years. I am sure that as FDA clearance becomes more imminent, Imaging3 will have its presence not only at the radiologists' meetings, but among those attended by cardiologists, vascular surgeons, orthopedic surgeons as well.
Medical doctors involved in being first to embrace revolutionary technology are sometimes looked upon as either "lunatics or luminaries" in advance of their colleagues eventually coming onboard over the following years. I like finding opportunities like IMGG, with medical technology that I am able to verify to a certain extent among colleagues I trust and respect. I got in early on in advance of FDA clearance for the Lasik technology and laser hair removal among others.
Stock price at this stage is largely affected by NEWS and MOMENTUM. I am a long term investor here, and already smiling that I established my position at $0.20. I look forward to major milestones to come.
News 
Market Data 
Discover 
AI
